Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HHS vs STRR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
STRR Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–4 Matrix Metrics)
STRR Overall Winner
6-Pillar Tally: HHS 2 – 3 STRR (1 Tie)
Matrix Metrics: HHS 4 – 5 STRR
As of Nov 16, 2026, Star Equity Holdings, Inc. (STRR) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas STRR carries 47.5/100 (HOLD) at $9.84 (8.8x Forward P/E, -2.6% operating margin).
- Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. STRR 47.5/100 HOLD), STRR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-2.6% vs. -3.2% operating margin) and revenue trajectory (+54.6% vs. -1.7% YoY).
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HHS vs STRR
HHS
Harte Hanks, Inc.
$3.84
-4.24% 1D
Market Cap
$30.0M
TTM Revenue
$155M
Forward P/E
14.3x
Beta / 30D Vol
0.49β · 46% Vol
Unified Composite Score
61.8
BUY
Tech 76.0
Fund 61.0
Flow 50.0
Mom 54.0
Weinstein Technical Phase
Neutral · Hold
STRR
Head-to-Head Winner
Star Equity Holdings, Inc. Common Stock
$9.84
-0.56% 1D
Market Cap
$37.3M
TTM Revenue
$210M
Forward P/E
8.8x
Beta / 30D Vol
0.12β · 48% Vol
Unified Composite Score
47.5
HOLD
Tech 68.0
Fund 51.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (HHS 2 – 3 STRR)
1. Valuation Multiples
STRR
Forward P/E
14.3x
8.8x
Trailing P/E
14.3x
10.6x
PEG Ratio
1.19x
2.03x
EV / Revenue
0.3x
0.3x
2. Growth & Scale
STRR
Revenue Growth (YoY)
-1.7%
+54.6%
Earnings Growth (YoY)
-90.3%
-21.6%
TTM Revenue (USD)
$155M
$210M
Market Cap
$30.0M
$37.3M
3. Profitability & Quality
STRR
Gross Margin
16.1%
8.2%
Operating Margin
-3.2%
-2.6%
Net Profit Margin
-3.7%
-4.3%
Return on Equity (ROE)
-30.4%
-18.2%
4. Balance Sheet & Cash Flow
HHS
Cash Generation (TTM)
-$4.5M
-$11M
Cash Flow Margin
-2.9%
-5.2%
Net Cash / Leverage
$17M Net Debt (1.10x D/E)
$19M Net Debt (0.44x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
HHS
OpEx & R&D Intensity
19.3% of Rev ($30M)
10.8% of Rev ($23M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Conglomerates Operator
Staffing & Employment Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HHS (4) vs STRR (5)| Institutional Metric | HHS | STRR | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $30.0M | $37.3M | Tie | |
| Trailing P/E Ratio | 14.3x | 10.6x | STRR | |
| Forward P/E Ratio | 14.3x | 8.8x | STRR | |
| Revenue Growth (YoY) | -1.7% | +54.6% | STRR | |
| Operating Margin (TTM) | -3.2% | -2.6% | STRR | |
| Net Profit Margin | -3.7% | -4.3% | HHS | |
| Return on Equity (ROE) | -30.4% | -18.2% | STRR | |
| 52-Week Range Position | 69% ($2–$5) | 38% ($9–$12) | HHS | |
| Beta / 30D Volatility | 0.49β · 46% Vol | 0.12β · 48% Vol | HHS | |
| Unified Institutional Score | 61.8 / 100 (BUY) | 47.5 / 100 (HOLD) | HHS | |
| Trailing 12M Revenue (USD) | $155M | $210M | Scale | |
| Gross Profit Margin (TTM) | 16.1% | 8.2% | Quality | |
| PEG Ratio & EV / Revenue | 1.19x PEG · 0.3x EV/Rev | 2.03x PEG · 0.3x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$4.5M ($17M Net Debt (1.10x D/E)) | -$11M ($19M Net Debt (0.44x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
STRR +10.8 pp
3M Horizon
HHS +66.28 pp
6M Horizon
HHS +37.24 pp
1Y Horizon
HHS +41.23 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HHS Revenue | STRR Revenue | HHS Op. Margin | STRR Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $280M | $70M | -9.1% | -7.8% | STRR |
| FY2019 | $220M | $90M | -9.9% | -1.8% | STRR |
| FY2020 | $180M | $100M | -6.0% | -2.6% | STRR |
| FY2021 | $190M | $170M | 3.9% | 2.6% | HHS |
| FY2022 | $210M | $200M | 7.3% | 4.6% | HHS |
| FY2023 | $190M | $160M | 1.8% | 0.9% | HHS |
| FY2024 | $190M | $140M | 1.1% | -2.7% | HHS |
| FY2025 | $160M | $170M | 0.2% | -2.1% | HHS |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HHS
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
STRR
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact STRR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HHS Moat Profile
Cyclical / Execution-Driven Positioning
Conglomerates Operator
OpEx & R&D Reinvestment
19.3% of Rev ($30M)
90D Engineering Disclosures
0 Published
STRR Moat Profile
Cyclical / Execution-Driven Positioning
Staffing & Employment Services Operator
OpEx & R&D Reinvestment
10.8% of Rev ($23M)
90D Engineering Disclosures
0 Published
Investor FAQ HHS vs STRR Key Questions & Quantitative Answers
As of Nov 16, 2026, Star Equity Holdings, Inc. (STRR) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas STRR carries 47.5/100 (HOLD) at $9.84 (8.8x Forward P/E, -2.6% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. STRR 47.5/100 HOLD), STRR captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-2.6% vs. -3.2% operating margin) and revenue trajectory (+54.6% vs. -1.7% YoY).
STRR leads the Growth & Scale pillar: HHS posts -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin), compared with STRR at +54.6% YoY revenue growth and -21.6% YoY earnings growth on $210M TTM revenue (8.2% gross margin, -2.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HHS cumulative revenue shifted -42.9% while STRR shifted +142.9%. In operating R&D and SG&A reinvestment, HHS deploys 19.3% of Rev ($30M) (0 90-day corporate R&D disclosures) versus 10.8% of Rev ($23M) (0 disclosures) for STRR.
STRR screens cheaper on headline valuation multiples. HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin), whereas STRR trades at 8.8x Forward P/E, 10.6x Trailing P/E, 2.03x PEG, and 0.3x EV/Revenue (-5.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HHS (-30.4% ROE) versus STRR (-18.2% ROE) capital efficiency.
In options market volatility and institutional positioning, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk). By comparison, STRR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.12β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
STRR vs HHS · Reverse Pair
HHS vs HNI
· Sector Peer
HHS vs HMN
· Sector Peer
HHS vs LEE
· Sector Peer
STRR vs KFRC
· Sector Peer
STRR vs KELYA
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem